HCA Healthcare, Inc. (NYSE:HCA) Receives $506.14 Consensus Price Target from Analysts

HCA Healthcare, Inc. (NYSE:HCA) has been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $506.1364.

A number of analysts have weighed in on the company. Oppenheimer reduced their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. UBS Group boosted their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Royal Bank Of Canada reduced their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th.

HCA Healthcare Trading Up 0.1%

HCA opened at $375.37 on Friday. The stock has a market cap of $83.27 billion, a price-to-earnings ratio of 12.91, a PEG ratio of 1.19 and a beta of 1.12. HCA Healthcare has a 1 year low of $330.00 and a 1 year high of $556.52. The stock has a fifty day moving average price of $419.68 and a 200 day moving average price of $469.05.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the business posted $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Institutional Investors Weigh In On HCA Healthcare

Several large investors have recently modified their holdings of HCA. Palisade Asset Management LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $26,000. Holos Integrated Wealth LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $29,000. Ares Financial Consulting LLC bought a new stake in HCA Healthcare during the 4th quarter worth approximately $31,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $33,000. Finally, JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $33,000. 62.73% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.